Financials
- Market Capitalization 2.4 B
- Employee 357
- Founded 2009
- CEO N/A
- Website www.nurixtx.com
- Headquarter Delaware, United States
- FIGI BBG00SDJ8M78
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1849 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.84 USD | -0.71% | -3.05% | +12.33% | +9.33% | 2.50 B USD | ||
| 1870 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 56.03 USD | -5.53% | -21.84% | -9.75% | -15.18% | 2.41 B USD | ||
| 1885 | VCEL Vericel Corporation - Common Stock | 45.82 USD | -3.52% | -1.82% | +20.99% | +26.05% | 2.34 B USD | ||
| 1887 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.23 USD | +4.83% | +0.68% | +67.47% | +571.57% | 2.46 B USD |
Frequently asked questions about Nurix Therapeutics, Inc. - Common stock
What is the Nurix Therapeutics, Inc. - Common stock stock price today?
The current price of Nurix Therapeutics, Inc. - Common stock (NRIX) is 23.12. Over the past 24 hours, the stock has changed by +1.81%. Follow the NRIX chart for real-time price dynamics.
What is the stock ticker of Nurix Therapeutics, Inc. - Common stock?
Nurix Therapeutics, Inc. - Common stock trades under the ticker NRIX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nurix Therapeutics, Inc. - Common stock stock going up?
NRIX has changed by -5.40% over the last week, +35.20% over the last month, and +106.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Nurix Therapeutics, Inc. - Common stock net income for the last quarter?
Nurix Therapeutics, Inc. - Common stock reported net income of -89.53 M for the last quarter. The previous quarter showed -87.17 M, which means net income changed by -2.71%.
How many employees does Nurix Therapeutics, Inc. - Common stock have?
As of the latest available data, Nurix Therapeutics, Inc. - Common stock has 357 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nurix Therapeutics, Inc. - Common stock EBITDA?
Nurix Therapeutics, Inc. - Common stock EBITDA is -95.76 M, and its EBITDA margin is -1 058.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nurix Therapeutics, Inc. - Common stock stock?
You can buy Nurix Therapeutics, Inc. - Common stock (NRIX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nurix Therapeutics, Inc. - Common stock stock?
Investing in Nurix Therapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NRIX chart and related analysis on metatrader.com as part of your research.